GOQii launches first of its kind one stop solution for Diabetes Care in India
An Integrated programme comprising of GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching
To address 10 lakh diabetes patients over 3 years
Get 2 HbA1c tests
Improve HbA1c levels by 1 % (percentage) point (8.4–-7.4) and win 1 gm Gold*
GOQii, a leading smart-tech-enabled preventive healthcare company that is focusing on Digital Therapeutics, launches the first of its kind integrated lifestyle medicine programme-the GOQii Diabetes Care for people diagnosed with Diabetes. The programme is initiated to help people with diabetes to manage their condition and take ownership of their health with external help and expert guidance.
The programme priced at Rs 6999/- comes with the offering of a GOQii Smart Vital Plus device, a connected Glucometer -Contour Plus+1 with 10 test strips, doctor consult, 2 HbA1c tests and 6 months personalised diabetes coaching. The price of the programme is extremely affordable, given that if one has to buy these various components separately it will cost an individual Rs 14,999/-
Once enrolled into the Diabetes Care Programme, the patient gets trusted and trained assistance for the Diabetes Journey to improve diabetes outcomes (Lower blood sugar levels, HbA1c, lipid levels) & other metabolic parameters (Lose weight, reduce BMI, more energy).
Statistics show that while the world diabetes rate is growing at 57%, India is leaping ahead of the world rate at 74%. In India, 10.4% of the adult population has diabetes. India has a diabetic population of 85 million and almost 49% of the population go undetected. Another 50 million are in the developing stage of diabetes. India’s national average of HbA1c stands at 8.5% which is an alarming rate. Given all these statistics, no wonder that India has been labelled as the diabetic capital of the World.
As per GOQii’s latest India Fit Report 2022, Over the last 5 years, people suffering from lifestyle diseases namely Diabetes have seen an increase from 7.9 % in 2017 to 13.2% in 2021. Report indicates that men have greater rates of diabetes at 14.5% vs Women. The study was done among over 5 million users. Diabetes is influenced by a number of variables which include a bad diet, stress, and lack of physical exercise and quality sleep. Obesity, advancing age, and a poor diet are all factors that contribute to Diabetes. Given the above data, and the fact that self care along with guidance and holistic lifestyle modification are key for managing diabetes, GOQii has launched this Diabetes Care programme.
GOQii is committed to helping people with Chronic Diseases like Diabetes and helps them take ownership of their health. Monitoring blood glucose levels regularly helps people with Diabetes adapt their diet and exercise, monitor the effects of Diabetes medications & understand the impact of stress & illness on blood sugar levels. The patients will be handheld on their journey with personalised advice by their coach on Nutrition, Physical Activity, Medication compliance by Nutritionists, Regular Diagnostics all leading towards helping the patients reduce their HbA1C levels.
Speaking about the launch, Vishal Gondal, Founder & CEO of GOQii said, “We are elated to launch the first of its kind ‘Diabetes Care programme’. GOQii is integrating personalised, real-time and actionable insights into the daily lives of people living with Diabetes, enabling improved quality of life and clinical outcomes. Our collaborations across the healthcare spectrum will help people with Diabetes access our self-care solution wherever they are; at home, chemist, medical clinic or at a diagnostic centre. This programme is a unique gamified approach to diabetes care. The concept of incentivising with gold to sustain lifestyle modification and adherence in managing chronic conditions such as diabetes is a novel patient centric approach,” Gondal added.
“At GOQii our vision is to help people with diabetes manage it better and take accountability of their health with external help and expert guidance to improve their quality of life and outcomes,” said Rajashree Menon, Business Head HealthCare, GOQii.
Dr.J.Jayaprakashsai, National RSSDI Technology Task Force Group, said,"GOQii Diabetes Care 1gm Gold Incentive for Diabetes Control is a Patient Centric Digital Solution for Adherence to Treatment and to Improve Quality of Life". Nation RSSDI is the National Research Society for the Study of Diabetes in India.
"Diabetes Management can be challenging especially with Covid19 pandemic. Technology can improve adherence to healthy lifestyle & compliance with treatment,” added Dr.Amit Gupta, Membership Advisory Group - American Diabetes Association (2021-2022), National Executive Council Member RSSDI, Joint Secretary Diabetes India.
GOQii is closely working with various Pharmaceutical Companies, Hospitals, Medical Device Providers such as Ascensia Diabetes Care India, SRL Diagnostics, Pharmarack Technologies- Pharmacy availability facilitators, to provide Integrated Digital Therapeutics solutions in Diabetes Management and also across therapy areas like NAFLD, GERD, Diabetes, Obesity, Gastrointestinal Disorders, Mental health, Stroke management, Cardiac Care, DVT, Long Covid Care, Cancer Care. All these programs are delivered in partnership with the Healthcare Providers via doctors and are monitored closely for patient engagement and clinical outcomes.
GOQii gains an upper edge in digital therapeutics as our smart wearable devices also have a CDSCO (Indian FDA) registration as a medical device and all data generated by GOQii devices is acceptable for clinical needs. Furthermore, GOQii data collection is subjected to HIPAA, GDPR and other relevant data protection regulation, as well as ISO 27799 - the foremost standard for information security management in health.